Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Añadir filtros








Intervalo de año
1.
Chinese Journal of Pathology ; (12): 372-376, 2010.
Artículo en Chino | WPRIM | ID: wpr-333243

RESUMEN

<p><b>OBJECTIVES</b>This study try to subclassify breast cancer into different prognostic subgroups according to immunohistochemical algorithm and discuss the relationship between subtypes and biological and clinical behavior and prognosis.</p><p><b>METHODS</b>One hundred and twenty-eight cases of infiltrative ductal carcinoma were studied using immunohistochemical staining with an antibody panel of ER, PR, HER2 and CK5/6 and subclassified referring to previous reports, and the 9 cases of HER2 positive subtype were tested using FISH.</p><p><b>RESULTS</b>The expression of ER, PR, HER2, and CK5/6 was detected in 67%, 45%, 27% and 27% cases, respectively. All cases were subclassified into five subgroups, with luminal A (55%), luminal B (20%), HER2 positive (7%), basal-like (10%) and unclassified cases (8%). Nine HER2 positive cases all showed amplification of HER2 gene. It was demonstrated that the luminal A group was associated with the best prognosis but the basal-like group worst by univariate analysis. Multivariate analysis demonstrated that both the clinical stage and immunohistochemical subtypes of tumor were related to overall survival. Menses status were different among these subtypes.</p><p><b>CONCLUSION</b>According to the expression of ER, PR, HER2 and CK5/6, infiltrative ductal carcinoma could be subclassified into five subgroups with different biological features and outcome, having a role in evaluating the prognosis and guiding the clinical treatment.</p>


Asunto(s)
Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Persona de Mediana Edad , Neoplasias de la Mama , Clasificación , Metabolismo , Patología , Carcinoma Basocelular , Metabolismo , Patología , Carcinoma Ductal de Mama , Clasificación , Metabolismo , Patología , Estudios de Seguimiento , Queratina-5 , Metabolismo , Queratina-6 , Metabolismo , Estadificación de Neoplasias , Pronóstico , Receptor ErbB-2 , Metabolismo , Receptores de Estrógenos , Metabolismo , Receptores de Progesterona , Metabolismo , Tasa de Supervivencia , Carga Tumoral
2.
Chinese Journal of Pathology ; (12): 247-252, 2007.
Artículo en Chino | WPRIM | ID: wpr-333915

RESUMEN

<p><b>OBJECTIVE</b>To investigate effects of P-glycoprotein (gp) substrate drugs on the expression of CD147 and MMP2 and 9 in multidrug resistant breast cancer cells.</p><p><b>METHODS</b>MDR human breast cancer cell line, MCF7/AdrR, and its sensitive parental line, MCF7, were treated with various concentrations of P-gp substrate drugs, including paclitoxel and vincristine, and P-gp nonsubstrate drugs, bleomycin, in serum-free media. At the end of the treatment, expressions of CD147 and MMP2 and 9 were determined by real-time PCR and western blot.</p><p><b>RESULTS</b>Increased expressions of CD147 and MMP2 and 9 were observed in multidrug resistant cancer cells compared with their parental MCF7 cells. After treatment with bleomycin, the expression of CD147 and MMP2 and 9 in both MCF7 and MCF7/AdrR cells remained unchanged (P > 0.05). However, treatment with paclitoxel and vincristine resulted in a remarkable over-expression of CD147 and MMP2 and 9 at both transcription and protein levels in MCF7/AdrR cell line (P < 0.05), while MCF7 cells failed to show similar response.</p><p><b>CONCLUSIONS</b>P-gp substrate drugs can greatly upregulate the expression of CD147 and MMP2 and 9 in multidrug resistant breast cancer cells, therefore enhancing the tumor metastatic capability.</p>


Asunto(s)
Femenino , Humanos , Miembro 1 de la Subfamilia B de Casetes de Unión a ATP , Farmacología , Antineoplásicos , Farmacología , Basigina , Genética , Neoplasias de la Mama , Metabolismo , Línea Celular Tumoral , Resistencia a Múltiples Medicamentos , Resistencia a Antineoplásicos , Regulación Neoplásica de la Expresión Génica , Metaloproteinasa 2 de la Matriz , Genética , Metabolismo , Metaloproteinasa 9 de la Matriz , Genética , Metabolismo , ARN Mensajero , Metabolismo
3.
Chinese Journal of Oncology ; (12): 192-195, 2006.
Artículo en Chino | WPRIM | ID: wpr-308385

RESUMEN

<p><b>OBJECTIVE</b>This study was designed to investigate the significance of hTERT mRNA in breast carcinogenesis and to explore the diagnostic efficacy, and to study the effect of tumor suppressor gene p53 on the expression of hTERT mRNA.</p><p><b>METHODS</b>The expression of hTERT mRNA was examined by in situ hybridization in 12 cases of normal breast tissue nearby cancer, 7 of simple ductal hyperplasia, 20 of atypical hyperplasia, 18 of ductal carcinoma in situ and 25 with invasive ductal carcinoma. The expression of p53 protein were examined by immunohistochemistry in 43 carcinomas.</p><p><b>RESULTS</b>hTERT was not detected in normal breast tissue nearby cancer and simple ductal hyperplasia. The positive rate of hTERT mRNA in atypical hyperplasia, ductal carcinoma in situ and invasive ductal carcinoma were 25.0%, 83.3% and 88.0%, respectively. The prevalence and intensity of hTERT mRNA expression were much greater in carcinoma than those in simple or atypical hyperplasia and normal breast tissue nearby cancer (P < 0.05). The expression of hTERT was not correlated with tumor size and lymph node metastasis (P > 0.05). The positive correlation between hTERT mRNA and p53 was found in breast carcinoma (r = 0.5540, P < 0.01).</p><p><b>CONCLUSION</b>hTERT mRNA expression is closely related to the malignant transformation of breast tissue. Semi-quantitative detection of hTERT mRNA expression in situ is helpful in differentiated diagnosis of carcinoma in situ and atypical hyperplasia. Inactivation of p53 may play a role in the transcriptive activation of hTERT gene in breast carcinoma.</p>


Asunto(s)
Adulto , Humanos , Persona de Mediana Edad , Mama , Metabolismo , Patología , Neoplasias de la Mama , Genética , Metabolismo , Patología , Carcinoma Ductal de Mama , Metabolismo , Patología , Carcinoma Intraductal no Infiltrante , Metabolismo , Patología , Diagnóstico Diferencial , Progresión de la Enfermedad , Hiperplasia , Metástasis Linfática , ARN Mensajero , Genética , Telomerasa , Genética , Proteína p53 Supresora de Tumor
4.
Chinese Journal of Industrial Hygiene and Occupational Diseases ; (12): 173-175, 2004.
Artículo en Chino | WPRIM | ID: wpr-271994

RESUMEN

<p><b>OBJECTIVE</b>To study DNA damages of liver cells in rats exposed to vinyl chloride monomer (VCM), and the expressions of DNA damage repair enzymes including O(6)-methyl guanine-DNA methyl transferase (MGMT), X-ray repair cross-complementing group 1 (XRCC1) and X-ray repair cross-complementing group 3 (XRCC3); and to explore the repair mechanism of DNA damage induced by VCM.</p><p><b>METHODS</b>Rats were exposed to VCM by intraperitoneal injection. DNA damages were detected by single cell gel electrophoresis (comet assay). The expressions of DNA damage repair enzymes were measured by immunohistochemical methods.</p><p><b>RESULTS</b>The percentages of comet cells in low, moderate, and high dose groups (11.75%, 12.38%, and 17.63%, respectively) were greater than that of control (5.67%). The latter two groups were significantly different from that of control (P < 0.05, P < 0.01). The expressions of MGMT and XRCC1 decreased, and XRCC3 increased with the dose of VCM increased. DNA damage was correlated with the expression of XRCC3 (r = 0.438, P = 0.067).</p><p><b>CONCLUSION</b>VCM can cause DNA damage of liver cells with dose-response relationship. DNA damage repair enzymes take part in the repairing of DNA damage induced by VCM.</p>


Asunto(s)
Animales , Masculino , Ratas , Carcinógenos , Toxicidad , Daño del ADN , Reparación del ADN , Proteínas de Unión al ADN , Genética , Metabolismo , Relación Dosis-Respuesta a Droga , Hígado , Biología Celular , Metabolismo , O(6)-Metilguanina-ADN Metiltransferasa , Genética , Metabolismo , Ratas Sprague-Dawley , Cloruro de Vinilo , Toxicidad , Proteína 1 de Reparación por Escisión del Grupo de Complementación Cruzada de las Lesiones por Rayos X
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA